Kyverna Therapeutics (KYTX) Other Non Operating Income (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Other Non Operating Income of -$21000.0 for Q1 2026, down 223.53% on a QoQ basis from $17000.0 in Q4 2025, and up 22.22% year-over-year from -$17181.8 in Q1 2025.
Kyverna Therapeutics (KYTX) Other Non Operating Income (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$21000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 22.22% year-over-year to -$21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78000.0 (up 14.29% YoY) and the FY2025 annual result came in at -$85000.0, up 5.56% from the prior year.
- Other Non Operating Income was -$21000.0 for Q1 2026 at Kyverna Therapeutics, down from $17000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $17000.0 in Q4 2025 and bottomed at -$53000.0 in Q3 2025.
- A 4-year average of -$19230.8 and a median of -$21000.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 766.67% — and 2025, when it surged 325.0%.
- Kyverna Therapeutics' Other Non Operating Income stood at -$32000.0 in 2023, then surged by 112.5% to $4000.0 in 2024, then jumped by 325.0% to $17000.0 in 2025, then sank by 223.53% to -$21000.0 in 2026.
- Business Quant data shows KYTX's Other Non Operating Income at -$21000.0 in Q1 2026, $17000.0 in Q4 2025, and -$53000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -32,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | -3,000.00 |